A detailed history of Evermay Wealth Management LLC transactions in Biogen Inc. stock. As of the latest transaction made, Evermay Wealth Management LLC holds 5 shares of BIIB stock, worth $868. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Previous 5 -0.0%
Holding current value
$868
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$212.02 - $267.71 $212 - $267
-1 Reduced 16.67%
5 $1,000
Q4 2023

Feb 09, 2024

BUY
$222.59 - $267.94 $222 - $267
1 Added 20.0%
6 $1,000
Q2 2022

Aug 15, 2022

SELL
$187.54 - $223.02 $7,501 - $8,920
-40 Reduced 88.89%
5 $1,000
Q1 2022

May 16, 2022

SELL
$193.77 - $244.14 $1,937 - $2,441
-10 Reduced 18.18%
45 $9,000
Q4 2021

Feb 14, 2022

SELL
$223.92 - $287.77 $6,045 - $7,769
-27 Reduced 32.93%
55 $13,000
Q2 2021

Aug 13, 2021

BUY
$259.0 - $414.71 $21,238 - $34,006
82 New
82 $28,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Evermay Wealth Management LLC Portfolio

Follow Evermay Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evermay Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evermay Wealth Management LLC with notifications on news.